News

Tiziana Life Sciences Receives FDA Clearance for Alzheimer’s Treatment

1 Mins read

Tiziana Life Sciences Ltd.’s stock (TLSA) soared 41% in premarket trade on Tuesday following the announcement that the microcap biotech has received clearance from the Food and Drug Administration (FDA) for its investigational new drug application for intranasal foralumab, a potential treatment for Alzheimer’s disease.

Targeting the Underlying Pathology of Alzheimer’s Disease

Foralumab presents a promising breakthrough in the treatment of Alzheimer’s disease as it targets the disease’s underlying pathology by addressing the resulting neuroinflammation caused by the accumulation of toxic proteins in the brain, according to a statement released by Tiziana.

Moving Forward with Phase 2 Trial

With FDA clearance in hand, Tiziana will now be able to move forward with their Phase 2 trial of this fully human anti-CD3 monoclonal antibody. The antibody acts by binding to the T cell receptor and effectively dampening inflammation by modulating T cell function. Tiziana highlights that this effect has already been demonstrated in patients with COVID-19, multiple sclerosis, as well as in healthy individuals.

A Step Closer to a Potential Breakthrough Treatment

The Phase 2 trial for foralumab is expected to commence in the third quarter, marking an important milestone for Tiziana Life Sciences in their pursuit of a groundbreaking treatment for Alzheimer’s disease. As of now, the stock has seen a 0.6% increase year-to-date.


Related posts
News

Semler Scientific Amplifies Bitcoin Investments, Solidifying Its Position in Digital Assets

1 Mins read
Semler’s strategic direction offers insights for other institutional investors.Trending NowBest Forex Trading Robots To Invest In 2022 U.S.-based medical technology company Semler…
News

IMF commends Sri Lanka's new govt for reform continuation

1 Mins read
COLOMBO, Apr 25: The International Monetary Fund (IMF) on Friday commended the Sri Lankan government, led by President Anura Kumara Dissanayake, for…
News

U.S. Federal Reserve revokes crypto guidance for banks

1 Mins read
25th April 2025 – (Washington) The U.S. Federal Reserve announced on 24th April that it will withdraw previous guidance requiring state member…

Leave a Reply

Your email address will not be published. Required fields are marked *

96 − = 92